Bank Of New York Mellon Corp Atreca, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.91 - $1.82 $28,944 - $57,888	31,807 New	31,807 $36.3 Million
Q4 2022 Feb 14, 2023	BUY	$0.78 - $1.68 $24,809 - $53,435	31,807 New	31,807 $25,000
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $133,050 - $277,189	-85,289 Reduced 72.76%	31,937 $57,000
Q1 2022 May 11, 2022	SELL	$1.61 - $5.2 $12,860 - $41,537	-7,988 Reduced 6.38%	117,226 $372,000
Q4 2021 Feb 11, 2022	SELL	$2.87 - $6.29 $1,366 - $2,994	-476 Reduced 0.38%	125,214 $380,000
Q3 2021 Nov 12, 2021	BUY	$4.91 - $9.07 $174,054 - $321,522	35,449 Added 39.28%	125,690 $783,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $13.8 $126,691 - $223,573	-16,201 Reduced 15.22%	90,241 $768,000
Q1 2021 May 13, 2021	SELL	$13.0 - $19.34 $48,308 - $71,867	-3,716 Reduced 3.37%	106,442 $1.63 Million
Q4 2020 Feb 09, 2021	BUY	$13.03 - $17.09 $292,901 - $384,166	22,479 Added 25.64%	110,158 $1.78 Million
Q3 2020 Nov 12, 2020	BUY	$12.67 - $23.19 $227,882 - $417,095	17,986 Added 25.81%	87,679 $1.22 Million
Q2 2020 Aug 12, 2020	BUY	$12.52 - $23.45 $269,205 - $504,221	21,502 Added 44.62%	69,693 $1.48 Million
Q1 2020 May 06, 2020	BUY	$11.4 - $27.28 $329,425 - $788,310	28,897 Added 149.77%	48,191 $797,000
Q4 2019 Feb 14, 2020	BUY	$9.68 - $18.67 $73,296 - $141,369	7,572 Added 64.6%	19,294 $298,000
Q3 2019 Nov 07, 2019	BUY	$10.42 - $22.04 $122,143 - $258,352	11,722 New	11,722 $143,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.